P

Inventor

DAMLE NITIN K

US23 patents
⚠️ This page may combine multiple inventors who share the name “DAMLE NITIN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

18 patents
US6623940B1Sep 23, 2003

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

BRISTOL MYERS SQUIBB CO133 citations99
US5977318ANov 2, 1999

CTLA4 receptor and uses thereof

BRISTOL MYERS SQUIBB CO438 citations99
US5968510AOct 19, 1999

CTLA4 receptor and uses thereof

BRISTOL MYERS SQUIBB CO157 citations99
US5885796AMar 23, 1999

CTLA4 receptor and uses thereof

BRISTOL MYERS SQUIBB CO199 citations99
US5885579AMar 23, 1999

CTLA4 receptor and uses thereof

BRISTOL MYERS SQUIBB CO122 citations99
US5851795ADec 22, 1998

Soluble CTLA4 molecules and uses thereof

BRISTOL MYERS SQUIBB CO182 citations99
US5844095ADec 1, 1998

CTLA4 Ig fusion proteins

BRISTOL MYERS SQUIBB CO417 citations99
US5580756ADec 3, 1996

B7Ig fusion protein

BRISTOL MYERS SQUIBB CO238 citations99
US5521288AMay 28, 1996

CD28IG fusion protein

BRISTOL MYERS SQUIBB CO233 citations99
US5434131AJul 18, 1995

Chimeric CTLA4 receptor and methods for its use

BRISTOL MYERS SQUIBB CO374 citations99
US6641809B1Nov 4, 2003

Method of regulating cellular processes mediated by B7 and CD28

BRISTOL MYERS SQUIBB CO84 citations98
US5770197AJun 23, 1998

Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules

BRISTOL MYERS SQUIBB CO200 citations98
US5709859AJan 20, 1998

Mixed specificity fusion proteins

BRISTOL MYERS SQUIBB CO143 citations98
US7311910B2Dec 25, 2007

Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions

BRISTOL MYERS SQUIBB CO40 citations96
US6887471B1May 3, 2005

Method to inhibit T cell interactions with soluble B7

BRISTOL MYERS SQUIBB CO66 citations96
US7070776B1Jul 4, 2006

Methods for blocking binding of CD28 receptor to B7

BRISTOL MYERS SQUIBB CO20 citations93
US6830937B1Dec 14, 2004

Method for generating and identifying antibodies directed against a B7

BRISTOL MYERS SQUIBB CO39 citations93
US7572772B2Aug 11, 2009

Soluble CTLA4 mutant molecules

BRISTOL MYERS SQUIBB CO10 citations83

WYETH LLC

2 patents

ASANA BIOSCIENCES LLC

2 patents

BOGHAERT ERWIN R

1 patent